Sansure Biotech Inc (688289) — Free Cash Flow Generation Index
Sansure Biotech Inc (688289) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-3.36 Million represents 0% of operating cash flow (CN¥59.72 Million). Read debt load of Sansure Biotech Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Sansure Biotech Inc across 8 annual periods. Explore 688289 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sansure Biotech Inc (2018–2025)
Year-by-year Free Cash Flow Generation Index for Sansure Biotech Inc. For the full company profile including market capitalisation, see how much is Sansure Biotech Inc worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | CN¥-185.81 Million | CN¥183.96 Million | CN¥369.77 Million | ▼ -89.0% |
| 2024 | -0.53x | CN¥-146.66 Million | CN¥274.45 Million | CN¥421.10 Million | ▲ +82.7% |
| 2023 | -3.08x | CN¥-347.81 Million | CN¥112.82 Million | CN¥391.35 Million | ▼ -494.4% |
| 2022 | 0.78x | CN¥2.00 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -2.5% |
| 2021 | 0.80x | CN¥1.50 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▼ -16.4% |
| 2020 | 0.96x | CN¥2.53 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▲ +283.1% |
| 2019 | -0.52x | CN¥-11.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +76.9% |
| 2018 | -2.27x | CN¥-22.84 Million | CN¥10.07 Million | CN¥32.90 Million | — |